New filler faces off against juvederm in Mid-Face volume trial
Symptom relief
Ongoing
This study compares a new injectable filler, JTM102, to an existing one (Juvederm VOLUMA) for temporarily restoring volume in the mid-face area. About 149 adults aged 19 to 65 who want to improve mid-face volume loss are participating. The goal is to see if JTM102 is safe and eff…
Phase: NA • Sponsor: Jetema Co., Ltd. • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC